I hope this helps: https://www.splitit.com/wp-content/uploads/2024/02/Primary-Markets-FAQ-Feb-2024.pdf
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%